Market Cap | ₹25,927Cr |
ROE | 1.12% |
P/E Ratio(TTM) | 282.68 |
EPS(TTM) | 0.69 |
P/B Ratio | 3.19 |
Dividend Yield | 0.07% |
Industry P/E | 34.95 |
Book Value | 61.17 |
Debt to Equity | 0.60 |
Face Value | 10 |
Parent Organisation | Piramal Pharma |
NSE Symbol | PPLPHARMA |
FUND NAME | AUM(%) |
---|---|
HDFC Focused 30 Fund Direct Growth | 2.53% |
HDFC Flexi Cap Direct Plan Growth | 2.30% |
HSBC Midcap Fund Direct Growth | 1.17% |
Canara Robeco Small Cap Fund Direct Growth | 1.12% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 141.79 | ||
Wockhardt | NA (0.00%) | -2336.28 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.81 | ||
Emcure Pharmaceuticals | NA (0.00%) | 36.90 |